Condition: Asthma
Interventions: Drug: FP 100mcg BID plus GSK2190915 100mg QD (AM); Drug: FP 100mcg BID plus GSK2190915 300mg QD (AM); Drug: FP 100mcg BID plus montelukast 10mg QD (PM); Drug: FP 100mcg BID plus placebo BID; Drug: FP/SAL 100/50mcg BID plus placebo BID
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days